Silicon Laboratories Inc.

Condensed Consolidated Balance Sheets 

(In thousands, except per share data) 

(Unaudited)

March 30,
2024

December 30,
2023

Assets

Current assets:

Cash and cash equivalents

$           191,489

$           227,504

Short-term investments

141,201

211,720

Accounts receivable, net

32,616

29,295

Inventories

198,206

194,295

Prepaid expenses and other current assets

82,608

75,117

Total current assets

646,120

737,931

Property and equipment, net

142,155

145,890

Goodwill

376,389

376,389

Other intangible assets, net

53,453

59,533

Other assets, net

126,036

123,313

Total assets

$        1,344,153

$        1,443,056

Liabilities and Stockholders' Equity

Current liabilities:

Accounts payable

$             44,575

$             57,498

Revolving line of credit

—

45,000

Deferred revenue and returns liability

3,921

2,117

Other current liabilities

62,863

58,955

Total current liabilities

111,359

163,570

Other non-current liabilities

67,233

70,804

Total liabilities

178,592

234,374

Commitments and contingencies

Stockholders' equity:

Preferred stock – $0.0001 par value; 10,000 shares authorized; no shares issued

—

—

Common stock – $0.0001 par value; 250,000 shares authorized; 31,924 and 31,897 shares issued and outstanding at March 30, 2024 and December 30, 2023, respectively

3

3

Additional paid-in capital

29,830

16,973

Retained earnings

1,136,205

1,192,731

Accumulated other comprehensive loss

(477)

(1,025)

Total stockholders' equity

1,165,561

1,208,682

Total liabilities and stockholders' equity

$        1,344,153

$        1,443,056